My Lp(a) Blood Test Is High: What Are the Next Steps in Dubai?
Discovered you have a high Lipoprotein(a) level? Learn what this genetic heart risk means and the practical, evidence-based steps you can take to manage your cardiovascular health in Dubai.
Understanding Lipoprotein(a) and Your Test Result
Receiving a high Lipoprotein(a) or Lp(a) blood test result can understandably cause concern. Unlike standard lipid panels that measure total cholesterol, high-density lipoprotein, and low-density lipoprotein, an Lp(a) test measures a specific type of lipoprotein particle. This particle is structurally similar to low-density lipoprotein but contains an additional protein called apolipoprotein(a). Medical bodies such as the Mayo Clinic emphasise that Lp(a) is an independent risk marker for cardiovascular diseases, including coronary artery disease, heart attacks, and strokes.
Understanding this distinction is vital for patients in Dubai who are navigating their health profiles. Standard lipid panels do not typically include Lp(a) unless specifically requested by a clinician, often following an unexplained cardiovascular event or a strong family history of premature heart disease. Because Lp(a) levels remain relatively stable throughout a person's life, a single elevated reading is sufficient to identify this specific genetic heart risk.
In the clinical setting, an elevated level is generally defined as anything above 50 milligrams per decilitre or 125 nanomoles per litre. However, the exact threshold for intervention depends heavily on your overall cardiovascular risk profile, your age, and other co-existing health conditions. Working with a qualified professional allows for a nuanced interpretation of these values rather than relying on automated laboratory reference ranges.
Why Traditional Lifestyle Changes Alone Do Not Lower Lp(a)
One of the most frustrating aspects of a high Lp(a) result for patients is learning that traditional lifestyle modifications have negligible impact on these specific levels. While a balanced diet, regular physical activity, and weight management are fundamental to general cardiovascular health, they do not significantly reduce Lp(a) levels. This is because your Lp(a) concentration is almost entirely determined by your genetics, specifically inherited variations in the LPA gene.
The National Institute for Health and Care Excellence in the United Kingdom and the European Society of Cardiology highlight that diet and exercise, which are highly effective at lowering standard LDL cholesterol, leave Lp(a) virtually unchanged. This genetic heart risk is present from birth, meaning even highly active individuals with exemplary dietary habits can present with elevated levels. Understanding this genetic component helps alleviate the self-blame that many patients experience upon receiving their lab reports.
Consequently, the clinical focus shifts from trying to force a reduction in the Lp(a) number itself to mitigating the overall systemic risk. Because Lp(a) promotes both plaque build-up in the arteries and blood clotting, managing every other modifiable risk factor becomes twice as important. This comprehensive approach is the cornerstone of modern preventative cardiology.
The Role of a Specialist or Cardiologist in Dubai
If you have received an elevated result, consulting a family physician or a cardiologist in Dubai is a critical next step. Dubai's unique demographic landscape, characterised by a diverse expat population and high-stress corporate environments, means that cardiovascular risk factors often cluster. Long working hours, a sedentary office culture, and extreme summer temperatures that limit outdoor exercise can compound genetic vulnerabilities.
A specialist will perform a comprehensive cardiovascular risk assessment. This goes beyond looking at your lipid panel in isolation. It involves evaluating your blood pressure, blood glucose levels, body composition, and family history. In many cases, a specialist may recommend advanced imaging, such as a Coronary Artery Calcium scan, to look for physical evidence of plaque accumulation in the coronary arteries.
This diagnostic precision is essential for tailoring a management plan that aligns with your specific risk profile. Under the regulatory framework of the Dubai Health Authority, clinicians in the emirate have access to state-of-the-art diagnostic facilities. This ensures that your management plan is guided by objective data rather than generalised assumptions.
Lipoprotein a Treatment and Risk Reduction Strategies
Currently, there are no widely approved pharmacological treatments specifically designed solely to lower Lp(a) levels. However, this does not mean there is nothing to be done. The primary therapeutic strategy is aggressive risk reduction. To counteract the excess risk posed by high Lp(a), clinical guidelines recommend lowering low-density lipoprotein cholesterol to much stricter target levels than would otherwise be required.
To achieve these stringent targets, a clinician may prescribe high-intensity statin therapy, often in combination with other lipid-lowering medications such as ezetimibe. Additionally, advanced therapies like PCSK9 inhibitors, which are administered via injection, have been shown to moderately reduce Lp(a) levels alongside dramatic reductions in LDL cholesterol. Your medical team will determine if these advanced therapies are appropriate for your clinical situation and compatible with your insurance coverage.
Beyond cholesterol management, optimising blood pressure and maintaining excellent glycemic control are non-negotiable. For patients who smoke, smoking cessation is the single most impactful lifestyle change to reduce the compounding risk of arterial thrombosis. Aspirin therapy may also be considered in specific high-risk scenarios, though this must be carefully balanced against individual bleeding risks under professional guidance.
The Importance of Family Screening and Genetic Awareness
Because elevated Lp(a) is an inherited trait, your result has important implications for your immediate family members. International guidelines, including those from the European Atherosclerosis Society, strongly recommend cascade screening. This means that first-degree relatives, including parents, siblings, and adult children, should also have their Lp(a) levels measured at least once.
Early identification of high Lp(a) in family members allows for early lifestyle and medical interventions, potentially preventing the premature onset of cardiovascular disease. In Dubai, where many expats live away from their extended families, sharing this information can be a life-saving act of preventative health communication. It enables relatives to seek testing in their respective home countries or here in the UAE.
Genetic awareness also helps de-stigmatise cardiovascular disease within families. It shifts the narrative from a perceived failure of lifestyle choices to an objective genetic variant that can be proactively managed. Knowing your genetic predisposition empowers you and your family to take control of your cardiovascular destiny long before symptoms ever develop.
Advanced Diagnostic Pathways in Dubai
In Dubai's advanced clinical landscape, managing high Lp(a) often involves sophisticated diagnostic pathways. Beyond standard blood tests, clinicians frequently utilise non-invasive imaging to assess the actual burden of cardiovascular disease. A Coronary Artery Calcium scan is a rapid, low-dose CT scan that measures calcified plaque in the coronary arteries, providing a highly accurate assessment of your current cardiovascular risk.
If the calcium scan reveals significant plaque accumulation, your clinical team can initiate more aggressive preventative therapies immediately. Conversely, a zero calcium score can provide reassurance, though it does not completely eliminate risk, especially in younger patients where non-calcified plaque may still be present. This personalised approach ensures that medical resources and therapies are directed where they are most needed.
Additionally, emerging therapies specifically targeting the genetic production of Lp(a) are currently in phase three clinical trials globally. These include antisense oligonucleotides and small interfering RNA therapies designed to silence the LPA gene in the liver. Dubai's medical community closely monitors these international developments, ensuring that local patients have access to cutting-edge treatments as soon as they are approved by global regulatory bodies and the Ministry of Health and Prevention.
Practical Next Steps and Your Consultation
If you have received a high Lp(a) result, the most constructive next step is to schedule a comprehensive consultation with a healthcare professional. Rather than experiencing anxiety over a laboratory report, partnering with a clinician allows you to translate this data into an actionable, personalised wellness strategy. Your consultation will focus on mapping out a clear pathway to safeguard your long-term cardiovascular health.
At Aafiyah Care Clinic, located at Unit G09, Churchill Executive Towers, Business Bay, Dubai, we provide comprehensive laboratory screening and clinical consultations. Our team is dedicated to helping you interpret complex diagnostic markers and establishing robust, evidence-based preventative care plans tailored to the unique demands of living and working in the UAE.
Please note that the information provided in this article is strictly for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare clinician regarding any medical condition or treatment plan. If you would like to discuss your cardiovascular risk factors, review your recent blood test results, or schedule a comprehensive lipid assessment, please contact our clinic to arrange a consultation or request a home visit.
Frequently asked
Can I lower my Lp(a) levels with diet and exercise?
No, dietary changes and physical exercise do not significantly lower Lp(a) levels, as they are determined almost entirely by genetics. However, maintaining a healthy lifestyle remains vital. It helps control other key cardiovascular risk factors, such as blood pressure, body weight, and blood glucose, reducing your overall heart risk.
What is a normal or high level of Lp(a)?
Generally, an Lp(a) level below 30 milligrams per decilitre (or 75 nanomoles per litre) is considered normal. Levels above 50 milligrams per decilitre (or 125 nanomoles per litre) are classified as high and indicate an increased cardiovascular risk. Your clinician will interpret these results in the context of your overall health profile.
Should my children or siblings get their Lp(a) tested?
Yes, international guidelines recommend that first-degree relatives of individuals with high Lp(a) should be screened. Since this is an inherited genetic trait, testing your siblings and adult children can help identify those at risk early, enabling them to implement proactive preventative cardiovascular strategies.
Can standard statins lower my Lp(a) levels?
Standard statins do not significantly lower Lp(a) levels and can sometimes cause a slight increase. However, they are still highly beneficial. Statins dramatically lower LDL cholesterol, which is crucial because reducing your overall cholesterol burden helps offset the cardiovascular risk associated with high Lp(a).
Are there any approved medical treatments specifically for reducing Lp(a)?
Currently, there are no widely approved drugs designed solely to target and lower Lp(a). However, advanced therapies like PCSK9 inhibitors can lower it moderately. Furthermore, promising new gene-silencing therapies are currently in advanced clinical trials globally and may become available in Dubai in the near future.
Book a consultation on WhatsApp
Speak with a British-trained GP at Aafiyah Care Clinic, Unit G09, Churchill Executive Towers, Business Bay, Dubai. We reply directly on WhatsApp — clinic visits and home visits available across Dubai.
Book a consultation on WhatsAppMedical disclaimer: The information in this article is provided for general educational and informational purposes only, in line with Dubai Health Authority (DHA) guidance. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a DHA-licensed clinician before starting, stopping, or changing any healthcare plan.